Scientists Just Figured Out How To Switch Off Chronic Pain at the Source
Restoring mu opioid receptors in a brain region reversed chronic pain in mice.
The brain's built-in system for stopping pain may be secretly keeping it alive.
Researchers at Washington University (WashU) School of Medicine in St. Louis discovered that long-term nerve injury flips a key brain region from a pain reliever into a chronic pain generator.
By restoring specific receptors within this brain region, the team successfully turned off chronic pain in mice without using opioid drugs.
How nerve damage drives chronic pain
Managing chronic pain caused by nerve damage from conditions such as diabetes, physical trauma, or viral infections remains a big challenge in health care.
“Millions of adults live with chronic neuropathic pain caused by nerve damage,” said senior author Dr. Jordan McCall, an associate professor in the Center for Clinical Pharmacology in the WashU Medicine Department of Anesthesiology. “The pain is difficult to treat, and traditional opioid medications bind to receptors throughout the entire body and brain, often leading to side effects, tolerance and addiction risk.”
Normally, a small cluster of cells at the base of the brain called the locus coeruleus helps quiet incoming pain signals. However, past studies have revealed a surprising paradox: over time, persistent nerve injury changes the natural pain-relieving center into a driver of chronic pain. Until now, researchers did not fully understand how nerve damage flips this biological switch, or which molecular gates control the transition.
“Understanding how localized receptors in the locus coeruleus act as gatekeepers could lead to more targeted, effective pain therapies with fewer risks,” said McCall.
McCall and the team studied mice to isolate specific nerve pathways connected to the locus coeruleus, in an attempt to track how receptors in this brain region control pain processing.
Mapping brain circuits that control chronic pain
The research team evaluated mice with nerve injuries by measuring their sensitivity to touch and temperature. To examine specific brain circuits without affecting nearby tissue, the researchers used light-sensitive proteins to turn off selected nerve cells in the locus coeruleus.
They also selectively removed mu opioid receptors from distinct neural pathways connecting this region to the prefrontal cortex, the spinal cord, or the hippocampus.
Mu opioid receptors
Mu opioid receptors are small proteins located on the surface of nerve cells that act as biological docking stations. When pain-relieving chemicals produced by the body—or synthetic opioid medicines—attach to these receptors, they quiet down nerve activity and block pain signals from traveling through the nervous system.
In healthy mice, shutting down locus coeruleus activity reduced sensitivity to pain. Shortly after nerve injury, silencing these cells provided only minimal relief, as the brain's natural pain-relieving controls were undergoing rewiring.
Four weeks after injury, once the rewiring was complete, turning off the same cells dramatically relieved sensitivity in the injured leg. The persistent nerve injury had turned the locus coeruleus into a hyperactive pain amplifier, and silencing it cut the power to the main engine driving the chronic pain.
In real-time preference tests, animals choose to spend more time in a room where a treatment offers emotional relief. While turning off key cells physically reduced pain sensitivity, the mice did not spend extra time in the treatment room, suggesting physical relief may not automatically trigger immediate emotional reward in short-term tests.
Removing opioid receptors from pathways leading to the prefrontal cortex made mice far more sensitive to pain. In contrast, removing receptors from pathways leading down to the spinal cord reduced pain sensitivity.
Using gene therapy to restore functional mu opioid receptors directly in the locus coeruleus completely reversed pain hypersensitivity in the mice.
Scale Up AAV Capture Without Sacrificing Recovery
This case study details how a contract manufacturer scaled AAV9 capture from 5 mL to 515 mL while preserving product quality.View App Note / Case Study
Targeted brain receptors offer hope for chronic pain
By focusing on specific receptors inside the locus coeruleus or targeting its connections to the prefrontal cortex, future medical treatments could offer relief without triggering widespread side effects across the body.
“These findings have broad implications for our understanding of the chronification of pain and point toward therapeutic solutions,” said the authors.
However, while promising, the study has several key limitations: the genetic tools used to modify cells affected a few nerve groups outside the main target area, and although turning off key cells provided physical relief, it did not produce clear changes in the real-time preference tests, suggesting that alternative tests may be needed to measure emotional pain relief.
Technical constraints also prevented the researchers from restoring receptors across multiple individual pathways simultaneously.
Future research is needed to identify which surrounding brain areas deliver natural opioids to these target cells. The team also plans to map how receptor levels shift over time as injury progresses, while testing improved genetic delivery systems.
“Further study of norepinephrine circuits and inhibitory signaling pathways in these neurons will bring us closer to successfully leveraging the locus coeruleus system as a target for the treatment of chronic neuropathic pain,” said the authors.
Reference: Kuo CC, Norris MR, Dunn SS, et al. Mu opioid receptors gate the locus coeruleus pain generator. Curr Biol. 2026:S0960982226009474. doi: 10.1016/j.cub.2026.07.048
Original story: Washington University School of Medicine in St. Louis
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
